Safety Study of NNZ-2566 in Healthy Subjects, Following Oral Administration

Clinical trial NCT01420042 · COMPLETED

Trial details

NCT number: NCT01420042
Sponsor: Neuren Pharmaceuticals Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain Injuries, Traumatic

Start date: 2012-02-01
Primary completion: 2012-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.